Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 29, 2019
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
Mayank Mamtani Initiated (ACST) at Strong Buy and Held Target at $372 on, Aug 29th, 2019
Mayank Mamtani of B. Riley Securities, Initiated "Acasti Pharma Inc." (ACST) at Strong Buy and Held Target at $372 on, Aug 29th, 2019.
Mayank has made no other calls on ACST in the last 4 months.
There is 1 other peer that has a rating on ACST. Out of the 1 peers that are also analyzing ACST, 0 agree with Mayank's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mayank
- Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $336 on, Thursday, July 18th, 2019
